Gene expression of cyclin-dependent kinase inhibitors and effect of heparin on their expression in mice with hypoxia-induced pulmonary hypertension

Biochemical and Biophysical Research Communications

Volumn 345, Issue 4, 2006, Pages 1565-1572

  Yu, Lunyin ^a   Quinn, Deborah A ^a   Garg, Hari G ^a   Hales, Charles A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

CDK inhibitor; Gene array; Heparin; Hypoxia; Mice; Pulmonary hypertension

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN DEPENDENT KINASE INHIBITOR 1C; CYCLIN DEPENDENT KINASE INHIBITOR 2B; CYCLIN DEPENDENT KINASE INHIBITOR 2C; CYCLIN DEPENDENT KINASE INHIBITOR 2D; HEPARIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; PROTEIN P16INK4A; SB 203508; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CYCLE REGULATION; CELL HYPOXIA; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; DNA MICROARRAY; DRUG EFFECT; EXPOSURE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; LUNG ARTERY; MEDIATOR; MOUSE; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SMOOTH MUSCLE FIBER; UPREGULATION;

ANIMALS; ANOXIA; CELL CYCLE PROTEINS; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE INHIBITOR P18; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASE INHIBITOR PROTEINS; CYCLINS; E2F4 TRANSCRIPTION FACTOR; FLAVONOIDS; GENE EXPRESSION; GENE EXPRESSION PROFILING; HEPARIN; HYPERTENSION, PULMONARY; IMIDAZOLES; MICE; MICE, INBRED STRAINS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PYRIDINES; RETINOBLASTOMA-LIKE PROTEIN P107;

EID: 33744510570     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.05.060     Document Type: Article

References (36)

1. Jeffery T.K., and Wanstall J.C. Pulmonary vascular remodeling: a target for therapeutic intervention in pulmonary hypertension. Pharmacol. Ther. 92 (2001) 1-20
2. Rabinovitch M. Pulmonary vascular remodeling in hypoxic pulmonary hypertension. In: Yuan J.X.-J. (Ed). Hypoxic Pulmonary Vasoconstriction: Cellular and Molecular Mechanisms (2004), Kluwer Academic Publishers, Dordrecht 403-418
3. Sandal T. Molecular aspects of the mammalian cell cycle and cancer. Oncologist 7 (2002) 73-81
4. Sherr C.J., and Roberts J.M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13 (1999) 1501-1512
5. Roninson I.B. Oncogenic functions of tumor suppressor p21 (Waf1/Cip1/Sdi1): association with cell senescence and tumor-promoting activities of stromal fibroblasts. Cancer Lett. 179 (2002) 1-14
6. F.C. Tanner, M. Boehm, L.M. Akyurek, H. San, Z.Y.Yang, J. Tashiro, G.J. Nabel, E.G. Nabel, Differential effects of the cyclin-dependent kinase inhibitors p27(Kip1), p21(Cip1), and p16(Ink4) on vascular smooth muscle cell proliferation, Circulation 101 (Circulation) 2022-2025.
7. Yang Z.Y., Simari R.D., Perkins N.D., San H., Gordon D., Nabel G.J., and Nabel E.G. Role of the p21 cyclin-dependent kinase inhibitor in limiting intimal cell proliferation in response to arterial injury. Proc. Natl. Acad. Sci. USA 93 (1996) 7905-7910
8. Khoury J., and Langleben D. Heparin-like molecules inhibit pulmonary vascular periocyte proliferation in vitro. Am. J. Physiol. Lung Cell Mol. Physiol. 279 (2000) L252-L261
9. Fouty B.W., Grimison B., Fagan K.A., Le Cras T.D., Harral J.W., Hoedt-Miller M., Sclafani R.A., and Rodman D.M. P27(KIP1) is important in modulating pulmonary artery smooth muscle cell proliferation. Am. J. Respir. Cell. Mol. Biol. 25 (2001) 652-658
10. Castro C., Diez-Juan A., Cortes M.J., and Andres V. Distinct regulation of mitogen-activated protein kinases and p27Kip1 in smooth muscle cells from different vascular beds. A potential role in establishing regional phenotypic variance. J. Biol. Chem. 278 (2003) 4482-4490
11. Yu L., Quinn D.A., Garg H.G., and Hales C.A. Cyclin-dependent kinase inhibitor p27Kip1, but not p21WAF1/Cip1, is required for inhibition of hypoxia-induced pulmonary hypertension and remodeling by heparin in mice. Circ. Res. 97 (2005) 937-945
12. Kyriakis J.M., and Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev. 81 (2001) 807-869
13. Davis B.B., Dong Y., and Weiss R.H. Overexpression of p73 causes apoptosis in vascular smooth muscle cells. Am. J. Physiol. Cell Physiol. 284 (2003) C16-C23
14. Delmas C., Aragou N., Poussard S., Cottin P., Darbon J.M., and Manenti S. MAP kinase-dependent degradation of p27Kip1 by calpains in choroidal melanoma cells. Requirement of p27Kip1 nuclear export. J. Biol. Chem. 278 (2003) 12443-12451
15. Fink L., Kohlhoff S., Stein M.M., Hänze J., Weissmann N., Rose F., Akkayagil E., Manz D., Grimminger F., Seeger W., and Bohle R.M. cDNA Array Hybridization after Laser-Assisted Microdissection from Nonneoplastic Tissue. Am. J. Pathol. 160 (2002) 81-90
16. Israels E.D., and Israels L.G. The cell cycle. Oncologist 5 (2000) 510-513
17. Sharov V.G.V.G., Todor A., Suzuki G., Morita H., Tanhehco E.J., and Sabbah H.N. Hypoxia, angiotensin-II, and norepinephrine mediated apoptosis is stimulus specific in canine failed cardiomyocytes: a role for p38 MAPK, Fas-L and cyclin D1. Eur. J. Heart Fail. 5 (2003) 121-129
18. Wykoff C.C., Sotiriou C., Cockman M.E., Ratcliffe P.J., Maxwell P., Liu E., and Harris A.L. Gene array of VHL mutation and hypoxia shows novel hypoxia-induced genes and that cyclin D1 is a VHL target gene. Br. J. Cancer. 90 (2004) 1235-1243
19. Conrad P.W., Rust R.T., Han J., Millhorn D.E., and Beitner-Johnson D. Selective activation of p38α and p38γ by hypoxia. Role in regulation of cyclin D1 by hypoxia in PC12 cells. J. Biol. Chem. 274 (1999) 23570-23576
20. Joung Y.H., Lim E.J., Lee M.Y., Park J.H., Ye S.K., Park E.U., Kim S.Y., Zhang Z., Lee K.J., Park D.K., Park T., Moon W.K., and Yang Y.M. Hypoxia activates the cyclin D1 promoter via the Jak2/STAT5b pathway in breast cancer cells. Exp. Mol. Med. 37 (2005) 353-364
21. Naldini A., and Carraro F. Hypoxia modulates cyclin and cytokine expression and inhibits peripheral mononuclear cell proliferation. J. Cell Physiol. 181 (1999) 448-454
22. Krtolica A.A., Krucher N.A., and Ludlow J.W. Molecular analysis of selected cell cycle regulatory proteins during aerobic and hypoxic maintenance of human ovarian carcinoma cells. Br. J. Cancer 80 (1999) 1875-1883
23. Zygmunt A., Tedesco V.C., Udho E., and Krucher N.A. Hypoxia stimulates p16 expression and association with cdk4. Exp. Cell Res. 278 (2002) 53-60
24. Seim J., Graff P., Amellem O., Landsverk K.S., Stokke T., and Pettersen E.O. Hypoxia-induced irreversible S-phase arrest involves down-regulation of cyclin A. Cell Prolif. 36 (2003) 321-332
25. Ludlow J.W., Howell R.L., and Smith H.C. Hypoxic stress induces reversible hypophosphorylation of pRB and reduction in cyclin A abundance independent of cell cycle progression. Oncogene 8 2 (1993) 331-339
26. Graff P., Amellem O., Seim J., Stokke T., and Pettersen E.O. The role of p27 in controlling the oxygen-dependent checkpoint of mammalian cells in late G1. Anticancer Res. 25 3B (2005) 2259-2267
27. Horiuchi A., Imai T., Shimizu M., Oka K., Wang C., Nikaido T., and Konishi I. Hypoxia-induced changes in the expression of VEGF, HIF-1α and cell cycle-related molecules in ovarian cancer cells. Anticancer Res. 22 5 (2002) 2697-2702
28. Bindra R.S., Gibson S.L., Meng A., Westermark U., Jasin M., Pierce A.J., Bristow R.G., Classon M.K., and Glazer P.M. Hypoxia-induced down-regulation of BRCA1 expression by E2Fs. Cancer Res. 65 24 (2005) 11597-11604
29. Wang G., Reisdorph R., Clark Jr. R.E., Miskimins R., Lindahl R., and Miskimins W.K. Cyclin dependent kinase inhibitor p27(Kip1) is upregulated by hypoxia via an ARNT dependent pathway. J. Cell. Biochem. 90 (2003) 548-560
30. Green S.L., Freoberg R.A., and Giaccia A.J. p21(Cip1) and p27(Kip1) regulate cell cycle reentry after hypoxic stress but are not necessary for hypoxia-induced arrest. Mol. Cell. Biol. 21 (2001) 1196-1206
31. Box A.H., and Demetrick D.J. Cell cycle kinase inhibitor expression and hypoxia-induced cell cycle arrest in human cancer cell lines. Carcinogenesis 25 (2004) 2325-2335
32. Hauck L., Hansmann G., Dietz R., and von Harsdorf R. Inhibition of hypoxia-induced apoptosis by modulation of retinoblastoma protein-dependent signaling in cardiomyocytes. Circ. Res. 91 (2002) 782-789
33. Salnikow K., Costa M., Figg W.D., and Blagosklonny M.V. Hyperinducibility of hypoxia-responsive genes without p53/p21-dependent checkpoint in aggressive prostate cancer. Cancer Res. 60 (2000) 5630-5634
34. Nyunoya T.T., Powers L.S., Yarovinsky T.O., Butler N.S., Monick M.M., and Hunninghake G.W. Hyperoxia induces macrophage cell cycle arrest by adhesion-dependent induction of p21Cip1 and activation of the retinoblastoma protein. J. Biol. Chem. 278 (2003) 36099-36106
35. Douglas R.M., Xu T., and Haddad G.G. Cell cycle progression and cell division are sensitive to hypoxia in Drosophila melanogaster embryos. Am. J. Physiol. Regul. Integr. Comp. Physiol. 280 (2001) R1555-R1563
36. Ottlinger M.E., Pukac L.A., and Karnovsky M.J. Heparin inhibits mitogen-activated protein kinase activation in intact rat vascular smooth muscle cells. J. Biol. Chem. 268 (1993) 19173-19176